In a recent study published on Journal of Clinical Medicine, there is now emerging evidence that obesity and overweight predispose to Covid-19 severe symptoms and negative prognosis
What are the best practises the tobacco industry should follow to achieve a sustainable change through the innovation and regulation? This was the question that this year’s Global Tobacco and Nicotine Forum, GTFN 2020, focused on
CoEHAR researchers call out the standardization of research methodologies on electronic cigarettes as a milestone for the effectiveness of the procedures to quit smoking
Presented in Italy the “Blue Book”, the document containing the results achieved last year by the Italian Customs and Monopoly Agency. The most impressive result was the contraction of 6.80% in…
According to a study lead by CoEHAR of the University of Catania, the e-liquids used in electronic cigarettes have antibacterial properties effective on different pathogens
In the past few days, seroepidemiological tests on citizens have been performed to assess the impact of smoking on the Covid-19 infections on the most vulnerable part of the population. The subjects of the study were selected according to a multi-layered probabilistic sampling plan by gender and age on citizens from 5 to over 80 years old. Among them, the employees of the Oasi of Troina, many of whom were tested positive to the Covid-19 infection.
An article published in the Lancet triggers the reaction of the scientific community that supports the tobacco harm reaction policies.
Talking about tobacco harm reduction means embracing a plurality of behaviors, choices and products that can be confusing. We have deepened the subject with Dr. Renée O’Leary, author of the paper and COEHAR researcher
Toxicological testing, population studies, clinical trials and randomized controlled trials demonstrate the potential reductions in exposures for smokers. Unfortunately, socio-cultural and economics barriers, such as heavy taxation, misperceptions about nicotine and unsubstantiated fears of youth addiction, prevent low risk products to become accessible to all and a good choice for those who want to quit smoking.
The Coehar Director, Giovanni Li Volti and the Co-project Leader for Replica, Dr. Massimo Caruso have organized a tour to all the international partners of the project to harmonize the protocols of the study for the first year of the Replica Project
We will send you direct emails, without intermediary services, you can withdraw in time by replying directly to the newsletter
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.